Advertisement

CardioVascular and Interventional Radiology

, Volume 39, Issue 10, pp 1372–1378 | Cite as

Comparative Study Using 100–300 Versus 300–500 μm Microspheres for Symptomatic Patients Due to Enlarged-BPH Prostates

  • Octavio Meneghelli Gonçalves
  • Francisco Cesar Carnevale
  • Airton Mota Moreira
  • Alberto Azoubel Antunes
  • Vanessa Cristina Rodrigues
  • Miguel Srougi
Clinical Investigation

Abstract

Purpose

The purpose of the study was to compare safety and efficacy outcomes following prostate artery embolization (PAE) for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) with 100–300 versus 300–500 μm tris-acryl gelatin microspheres.

Materials and Methods

Patients were prospectively treated between August 2011 and June 2013 to receive PAE with 100–300 μm (group A) or 300–500 μm (group B) tris-acryl gelatin microspheres. Patients were followed for a minimum of 12 months and were assessed for changes in International Prostate Symptom Score (IPSS), quality of life (QoL) index, prostate volume determined by magnetic resonance imaging, serum prostate specific antigen (PSA), and maximum urine flow rate (Qmax), as well as any treatment-related adverse events.

Results

Fifteen patients were included in each group, and PAE was technically successful in all cases. Both groups experienced significant improvement in mean IPSS, QoL, prostate volume, PSA, and Qmax (p < 0.05 for all). The differences observed between the two groups included a marginally insignificant more adverse events (p = 0.066) and greater mean serum PSA reduction at 3 months of follow-up (p = 0.056) in group A.

Conclusions

Both 100–300 and 300–500 μm microspheres are safe and effective embolic agents for PAE to treat LUTS-related to BPH. Although functional and imaging outcomes did not differ significantly following use of the two embolic sizes, the greater incidence of adverse events with 100–300 μm microspheres suggests that 300–500 μm embolic materials may be more appropriate.

Keywords

Arterial intervention Embolization Embolotherapy Prostate 

Abbreviations

BPH

Benign prostatic hyperplasia

BOO

Bladder outlet obstruction

IPSS

International Prostate Symptom Score

LUTS

Lower urinary tract symptoms

MRI

Magnetic resonance imaging

Qmax

Maximum urinary flow rate

PVA

Polyvinyl alcohol

PSA

Prostate-specific antigen

PAE

Prostatic artery embolization

QoL

Quality of life index

TURP

Transurethral resection of the prostate

Notes

Acknowledgments

The authors thank Sardis Honoria Harward for her important collaboration.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no financial disclosure.

Ethical Approval

All procedures performed in this study were in accordance with the Ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolisation. J Vasc Intervent Radiol. 2000;11:767–70.CrossRefGoogle Scholar
  2. 2.
    Carnevale FC, Antunes AA, da Motta Leal Filho JM, et al. Prostatic artery embolisation as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Carnevale FC, da Motta Leal Filho JM, Antunes AA, et al. Midterm follow-up after prostate embolisation in two patients with benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2011;34(6):1330–3.CrossRefPubMedGoogle Scholar
  4. 4.
    Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG. Prostatic arterial embolisation to treat benign prostatic hyperplasia. J Vasc Intervent Radiol. 2011;22:11–9.CrossRefGoogle Scholar
  5. 5.
    Carnevale FC, Antunes AA. Prostatic artery embolisation for enlarged prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Intervent Radiol. 2013;36(6):1452–63.CrossRefPubMedGoogle Scholar
  6. 6.
    Bilhim T, Pisco J, Campos Pinheiro L, et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolisation for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Intervent Radiol. 2013;24:1595–602.CrossRefGoogle Scholar
  7. 7.
    Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolisation first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014;37(6):1602–5.CrossRefPubMedGoogle Scholar
  8. 8.
    National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 4.0. US Department of Health and Human Services, National Institute of Health Publication no. 09-5410. Bethesda: NIH; 2009.Google Scholar
  9. 9.
    Moreira AM, Marques CF, Antunes AA, Nahas CS, Nahas SC, de Gregorio MA, et al. Transient ischemic rectitis as a potential complication after prostatic artery embolisation: case report and review of the literature. Cardiovasc Intervent Radiol. 2013;36(6):1690–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Carnevale FC, da Motta Leal Filho JM, Antunes AA, et al. Quality of life and clinical symptom improvement support prostatic artery embolisation for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Intervent Radiol. 2013;24:535–42.CrossRefGoogle Scholar
  11. 11.
    Pisco JM, Rio Tinto H, Campos Pinheiro L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23:2561–72.CrossRefPubMedGoogle Scholar
  12. 12.
    Antunes AA, Carnevale FC, da Motta-Leal-Filho JM, et al. Clinical, laboratorial and urodynamic findings of prostatic artery embolisation for the treatment of urinary retention related to benign prostatic hyperplasia. a prospective singe-center pilot study. Cardiovasc Intervent Radiol. 2013;36:978–86.CrossRefPubMedGoogle Scholar
  13. 13.
    Bagla S, Martin CP, van Breda A, et al. Early Results from a United States Trial of Prostatic Artery Embolisation in the Treatment of Benign Prostatic Hyperplasia. J Vasc Interv Radiol. 2014;25:47–52.CrossRefPubMedGoogle Scholar
  14. 14.
    Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Prostatic artery embolisation for treatment of benign prostatic hyperplasia in patients with prostates >90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26(1):87–93.CrossRefPubMedGoogle Scholar
  15. 15.
    Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolisation for treatment of benign hyperplasia. Am J Roentgenol. 2013;203:813–21.CrossRefGoogle Scholar
  16. 16.
    Brook OR, Faintuch S, Brook A, et al. Embolisation therapy for benign prostatic hyperplasia: influence of embolisation particle size on gland perfusion. J Magn Reson Imag. 2013;38:380–7.CrossRefGoogle Scholar
  17. 17.
    Wang M, Guo L, Duan F, et al. Prostatic arterial embolisation for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: a prospective single-center investigation. Int J Urol. 2015;22(8):766–72.CrossRefPubMedGoogle Scholar
  18. 18.
    Amouyal G, Thiounn N, Pellerin O, Yen-Ting L, Del Giudice C, Dean C, Pereira H, Chatellier G, Sapoval M. Clinical results after prostatic artery embolisation using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol. 2016;39(3):367–75.CrossRefPubMedGoogle Scholar
  19. 19.
    Laborda A, de Assis AM, Ioakeim I, Sánchez-Ballestin M, Carnevale FC, de Gregorio MA. Radiodermatitis after prostatic artery embolisation: case report and review of the literature. Cardiovasc Intervent Radiol. 2015;38:755–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2016

Authors and Affiliations

  • Octavio Meneghelli Gonçalves
    • 1
  • Francisco Cesar Carnevale
    • 1
  • Airton Mota Moreira
    • 1
  • Alberto Azoubel Antunes
    • 2
  • Vanessa Cristina Rodrigues
    • 1
  • Miguel Srougi
    • 2
  1. 1.Interventional Radiology UnitUniversity of Sao Paulo Medical SchoolSao PauloBrazil
  2. 2.Division of UrologyUniversity of Sao Paulo Medical SchoolSao PauloBrazil

Personalised recommendations